News | June 01, 2022
NATCO launches first generic version of Nexavar Tablets in the US
The product will be launched by NATCO's commercial partner Viatris.
The product will be launched by NATCO's commercial partner Viatris.
OS-SiA is the industry’s first AI-enabled digital scanner that will provide real-time predictive analysis and actionable insights
The Innovation Explorer database of GlobalData’s Disruptor Intelligence Center highlights how blockchain ensures the authenticity of products thereby, improves trust, traceability, and transparency across key sectors
Dr Jitendra Singh said, the Biotech Park would act as a hub for incubation of new ideas
Opdivo-based treatments are now approved for five indications in upper gastroesophageal cancers
Manamed, a pioneering Medical Technology development company, has been granted FDA approval on its latest orthopaedic recovery device, ManaSport.
Researchers found that the drug combination led to a sustained and tenfold increase in the production of CD8 T cells and natural killer cells
Lung cancer is the leading cause of cancer death in the USA, making up almost 25% of all cancer deaths
Glofitamab has the potential to offer a readily available, fixed-duration CD20xCD3 bispecific antibody treatment approach for people with aggressive lymphoma
The acquisition is subject to customary closing conditions and necessary regulatory approvals. The financial terms of the transaction are confidential
Subscribe To Our Newsletter & Stay Updated
